EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
24/12/2025
Voltar para busca
Dado oficial do USPTO
CINPINETY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
26/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35
Data de depósito
01/02/2023
Data de registro
30/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2024
Última transação
26/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CN
Examinador
FLETCHER,TRACY L
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Representantes
Scot A. Duvall STITES & HARBISON PLLC
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; vaccines; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; medicines for human purposes for the prevention and treatment of respiratory system disorders; medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; medicines for human purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; diagnostic preparations for medical purposes; dietetic foods and beverages adapted for medical use; dietetic preparations adapted for medical purposes, namely, dietetic foods and beverages adapted for medical use; protein supplements for animals; absorbent wadding for medical purposes
Classe 35
Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; commercial administration of the licensing of the goods and services of others; providing television home shopping services in the field of general consumer merchandise; advertising services
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/12/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/05/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/05/2024
FIMP
FINAL DISPOSITION PROCESSED
01/05/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/11/2023
PUBO
PUBLISHED FOR OPPOSITION
14/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
13/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/10/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/10/2023
GNFR
FINAL REFUSAL E-MAILED
03/10/2023
CNFR
FINAL REFUSAL WRITTEN
03/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/09/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/09/2023
RFNT
REFUSAL PROCESSED BY IB
05/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/06/2023
RFRR
REFUSAL PROCESSED BY MPU
11/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/04/2023
CNRT
NON-FINAL ACTION WRITTEN
27/04/2023
DOCK
ASSIGNED TO EXAMINER
26/04/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/04/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CINPINETY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.